Skip to main content
. 2010 Jun 1;105(10):2218–2227. doi: 10.1038/ajg.2010.218

Table 5. Clinical outcomes.

  Per-protocol
Intention-to-treat
  VSL#3 Placebo P value VSL#3 Placebo P value
≥50% Improvement in UCDAI (week 8) 41 29 0.010 41 29 0.031
>3 Decrease in UCDAI score (week 8) 39 29 0.017 39 28 0.046
Remission (week 8) 31 23 0.069 31 23 0.132

UCDAI, ulcerative colitis disease activity index.